[
  {
    "ts": "2025-11-27T13:23:00+00:00",
    "headline": "HOLX vs. DGX: Which Healthcare Diagnostics Stock Is the Better Bet?",
    "summary": "DGX's strong YTD gains and momentum in advanced diagnostics and acquisitions highlight why it may stand out in the competitive testing market against HOLX.",
    "url": "https://finance.yahoo.com/news/holx-vs-dgx-healthcare-diagnostics-132300160.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "370baad8-e68a-3b00-8865-abef47ed4583",
      "content": {
        "id": "370baad8-e68a-3b00-8865-abef47ed4583",
        "contentType": "STORY",
        "title": "HOLX vs. DGX: Which Healthcare Diagnostics Stock Is the Better Bet?",
        "description": "",
        "summary": "DGX's strong YTD gains and momentum in advanced diagnostics and acquisitions highlight why it may stand out in the competitive testing market against HOLX.",
        "pubDate": "2025-11-27T13:23:00Z",
        "displayTime": "2025-11-27T13:23:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/181d5ab1675d8aae9c53428215552644",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/ZwoKmvWtG4m50IBSf0NKDQ--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/181d5ab1675d8aae9c53428215552644.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/LkiDNdOPbO2HoLFk.M.nKA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/181d5ab1675d8aae9c53428215552644.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/holx-vs-dgx-healthcare-diagnostics-132300160.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/holx-vs-dgx-healthcare-diagnostics-132300160.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "HOLX"
            },
            {
              "symbol": "DGX"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-27T16:30:05+00:00",
    "headline": "Chemed (CHE) Down 5.2% Since Last Earnings Report: Can It Rebound?",
    "summary": "Chemed (CHE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.",
    "url": "https://finance.yahoo.com/news/chemed-che-down-5-2-163005677.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "4e3bd9c1-f35d-372f-a465-33fd5de7f200",
      "content": {
        "id": "4e3bd9c1-f35d-372f-a465-33fd5de7f200",
        "contentType": "STORY",
        "title": "Chemed (CHE) Down 5.2% Since Last Earnings Report: Can It Rebound?",
        "description": "",
        "summary": "Chemed (CHE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.",
        "pubDate": "2025-11-27T16:30:05Z",
        "displayTime": "2025-11-27T16:30:05Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/0c6f98f4bf655bec3b199bc1a71b8b85",
          "originalWidth": 900,
          "originalHeight": 636,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/eN0EvS2DQjGO_6Aa8hYV4w--~B/aD02MzY7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/0c6f98f4bf655bec3b199bc1a71b8b85.cf.webp",
              "width": 900,
              "height": 636,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/IXPNK2bXbxtvuH6_.DBDbA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/0c6f98f4bf655bec3b199bc1a71b8b85.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/chemed-che-down-5-2-163005677.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/chemed-che-down-5-2-163005677.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "CHE"
            },
            {
              "symbol": "DGX"
            },
            {
              "symbol": "^GSPC"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]